REVB
Income statement / Annual
Last year (2025), Revelation Biosciences Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Revelation Biosciences Inc's net income was -$8.91 M.
See Revelation Biosciences Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$27.06 K
|
$27.92 K
|
$25.05 K
|
$40.01 K
|
$69.17 K
|
$0.00
|
$0.00
|
| Gross Profit |
-$27.06 K
|
-$27.92 K
|
-$25.05 K
|
-$40.01 K
|
-$69.17 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$4.06 M
|
$3.55 M
|
$4.15 M
|
$5.38 M
|
$6.91 M
|
$2.56 M
|
$0.00
|
| General & Administrative Expenses |
$5.01 M
|
$4.43 M
|
$4.51 M
|
$5.49 M
|
$5.04 M
|
$1.23 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.01 M
|
$4.43 M
|
$4.51 M
|
$5.49 M
|
$5.04 M
|
$1.23 M
|
$3.64 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$9.07 M
|
$7.98 M
|
$8.66 M
|
$10.86 M
|
$11.95 M
|
$3.80 M
|
$3.64 K
|
| Cost And Expenses |
$9.07 M
|
$7.98 M
|
$8.66 M
|
$10.86 M
|
$11.95 M
|
$3.80 M
|
$3.64 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$10.92 K
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$41.76 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$27.06 K
|
$27.92 K
|
$25.05 K
|
$25.05 K
|
$16.78 K
|
$3.80 M
|
$0.00
|
| EBITDA |
-$9.04 M |
-$7.95 M |
-$8.63 M |
-$10.84 M |
-$11.93 M |
$0.00 |
-$3.64 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$157.17 K
|
-$7.06 M
|
$8.54 M
|
$34.96 K
|
-$36.35 K
|
$126.00
|
$0.00
|
| Income Before Tax |
-$8.91 M
|
-$15.04 M
|
-$120.25 K
|
-$10.83 M
|
-$11.99 M
|
-$3.80 M
|
-$3.64 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$8.91 M
|
-$15.04 M
|
-$120.25 K
|
-$10.83 M
|
-$11.99 M
|
-$1.63 M
|
-$3.64 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-23.95 |
-87.68 |
-8.41 |
-9643.37 |
-20400 |
-9032.69 |
-6.72 |
| EPS Diluted |
-23.95 |
-87.68 |
-8.41 |
-9643.37 |
-20400 |
-9032.69 |
-6.72 |
| Weighted Average Shares Out |
$620.80 K
|
$171.51 K
|
$14.29 K
|
$1.12 K
|
$587.58
|
$180.51
|
$541.53
|
| Weighted Average Shares Out Diluted |
$620.80 K
|
$171.51 K
|
$14.29 K
|
$1.12 K
|
$587.58
|
$180.51
|
$541.53
|
| Link |
|
|
|
|
|
|
|
